Lyophilized Injectable Market (By Type of Packaging: Single-use Vials, Point-of-care Reconstitution, Specialty Packaging; By Type of Delivery: Prefilled Diluent Syringes, Proprietary Reconstitution Devices, Single-step Devices, Multi-step Devices; By Indication; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Lyophilized Injectable Market, By Type of Packaging

7.1.  Lyophilized Injectable Market, by Type of Packaging, 2021-2030

7.1.1.     Single-use Vials

7.1.1.1.          Market Revenue and Forecast (2016-2030)

7.1.2.     Point-of-care Reconstitution

7.1.2.1.          Market Revenue and Forecast (2016-2030)

7.1.3.     Specialty Packaging

7.1.3.1.          Market Revenue and Forecast (2016-2030)

Chapter 8.    Global Lyophilized Injectable Market, By Type of Delivery

8.1.  Lyophilized Injectable Market, by Type of Delivery, 2021-2030

8.1.1.     Prefilled Diluent Syringes

8.1.1.1.          Market Revenue and Forecast (2016-2030)

8.1.2.     Proprietary Reconstitution Devices

8.1.2.1.          Market Revenue and Forecast (2016-2030)

8.1.3.     Single-step Devices

8.1.3.1.          Market Revenue and Forecast (2016-2030)

8.1.4.     Multi-step Devices

8.1.4.1.          Market Revenue and Forecast (2016-2030)

Chapter 9.    Global Lyophilized Injectable Market, By Indication

9.1.  Lyophilized Injectable Market, by Indication, 2021-2030

9.1.1.     Autoimmune Diseases

9.1.1.1.          Market Revenue and Forecast (2016-2030)

9.1.2.     Metabolic Conditions

9.1.2.1.          Market Revenue and Forecast (2016-2030)

9.1.3.     Infectious Diseases

9.1.3.1.          Market Revenue and Forecast (2016-2030)

9.1.4.     Others

9.1.4.1.          Market Revenue and Forecast (2016-2030)

Chapter 10.Global Lyophilized Injectable Market, By End User

10.1.          Lyophilized Injectable Market, by End User, 2021-2030

10.1.1.  Hospitals

10.1.1.1.       Market Revenue and Forecast (2016-2030)

10.1.2.  Ambulatory Surgical Centers

10.1.2.1.       Market Revenue and Forecast (2016-2030)

10.1.3.  Specialty Clinics

10.1.3.1.       Market Revenue and Forecast (2016-2030)

10.1.4.  Others

10.1.4.1.       Market Revenue and Forecast (2016-2030)

Chapter 11.Global Lyophilized Injectable Market, Regional Estimates and Trend Forecast

11.1.          North America

11.1.1.  Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.1.2.  Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.1.3.  Market Revenue and Forecast, by Indication (2016-2030)

11.1.4.  Market Revenue and Forecast, by End User (2016-2030)

11.1.5.  U.S.

11.1.5.1.       Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.1.5.2.       Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.1.5.3.       Market Revenue and Forecast, by Indication (2016-2030)

11.1.5.4.       Market Revenue and Forecast, by End User (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.       Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.1.6.2.       Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.1.6.3.       Market Revenue and Forecast, by Indication (2016-2030)

11.1.6.4.       Market Revenue and Forecast, by End User (2016-2030)

11.2.          Europe

11.2.1.  Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.2.2.  Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.2.3.  Market Revenue and Forecast, by Indication (2016-2030)

11.2.4.  Market Revenue and Forecast, by End User (2016-2030)

11.2.5.  UK

11.2.5.1.       Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.2.5.2.       Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.2.5.3.       Market Revenue and Forecast, by Indication (2016-2030)

11.2.5.4.       Market Revenue and Forecast, by End User (2016-2030)

11.2.6.  Germany

11.2.6.1.       Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.2.6.2.       Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.2.6.3.       Market Revenue and Forecast, by Indication (2016-2030)

11.2.6.4.       Market Revenue and Forecast, by End User (2016-2030)

11.2.7.  France

11.2.7.1.       Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.2.7.2.       Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.2.7.3.       Market Revenue and Forecast, by Indication (2016-2030)

11.2.7.4.       Market Revenue and Forecast, by End User (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.       Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.2.8.2.       Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.2.8.3.       Market Revenue and Forecast, by Indication (2016-2030)

11.2.8.4.       Market Revenue and Forecast, by End User (2016-2030)

11.3.          APAC

11.3.1.  Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.3.2.  Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.3.3.  Market Revenue and Forecast, by Indication (2016-2030)

11.3.4.  Market Revenue and Forecast, by End User (2016-2030)

11.3.5.  India

11.3.5.1.       Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.3.5.2.       Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.3.5.3.       Market Revenue and Forecast, by Indication (2016-2030)

11.3.5.4.       Market Revenue and Forecast, by End User (2016-2030)

11.3.6.  China

11.3.6.1.       Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.3.6.2.       Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.3.6.3.       Market Revenue and Forecast, by Indication (2016-2030)

11.3.6.4.       Market Revenue and Forecast, by End User (2016-2030)

11.3.7.  Japan

11.3.7.1.       Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.3.7.2.       Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.3.7.3.       Market Revenue and Forecast, by Indication (2016-2030)

11.3.7.4.       Market Revenue and Forecast, by End User (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.       Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.3.8.2.       Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.3.8.3.       Market Revenue and Forecast, by Indication (2016-2030)

11.3.8.4.       Market Revenue and Forecast, by End User (2016-2030)

11.4.          MEA

11.4.1.  Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.4.2.  Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.4.3.  Market Revenue and Forecast, by Indication (2016-2030)

11.4.4.  Market Revenue and Forecast, by End User (2016-2030)

11.4.5.  GCC

11.4.5.1.       Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.4.5.2.       Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.4.5.3.       Market Revenue and Forecast, by Indication (2016-2030)

11.4.5.4.       Market Revenue and Forecast, by End User (2016-2030)

11.4.6.  North Africa

11.4.6.1.       Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.4.6.2.       Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.4.6.3.       Market Revenue and Forecast, by Indication (2016-2030)

11.4.6.4.       Market Revenue and Forecast, by End User (2016-2030)

11.4.7.  South Africa

11.4.7.1.       Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.4.7.2.       Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.4.7.3.       Market Revenue and Forecast, by Indication (2016-2030)

11.4.7.4.       Market Revenue and Forecast, by End User (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.       Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.4.8.2.       Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.4.8.3.       Market Revenue and Forecast, by Indication (2016-2030)

11.4.8.4.       Market Revenue and Forecast, by End User (2016-2030)

11.5.          Latin America

11.5.1.  Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.5.2.  Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.5.3.  Market Revenue and Forecast, by Indication (2016-2030)

11.5.4.  Market Revenue and Forecast, by End User (2016-2030)

11.5.5.  Brazil

11.5.5.1.       Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.5.5.2.       Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.5.5.3.       Market Revenue and Forecast, by Indication (2016-2030)

11.5.5.4.       Market Revenue and Forecast, by End User (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.       Market Revenue and Forecast, by Type of Packaging (2016-2030)

11.5.6.2.       Market Revenue and Forecast, by Type of Delivery (2016-2030)

11.5.6.3.       Market Revenue and Forecast, by Indication (2016-2030)

11.5.6.4.       Market Revenue and Forecast, by End User (2016-2030)

Chapter 12.   Company Profiles

12.1.                 B. Braun Melsungen AG

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.                 Baxter International Inc

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.                 BD

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.                 Schott AG

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.                 Aristopharma Ltd.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.                 Vetter Pharma

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.                 Jubilant HollisterStier LLC.

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

Chapter 13.   Research Methodology

13.1.                 Primary Research

13.2.                 Secondary Research

13.3.                 Assumptions

Chapter 14.   Appendix

14.1.                 About Us

14.2.                 Glossary of Terms